What’s Next—Amylin-based Therapies
We are entering an era of choice in terms of diabetes and obesity therapies. Choice is good, but having a keen understanding of each medication is crucial to avoid being…
A monthly podcast devoted to presenting and discussing the latest clinically relevant articles from ADA’s scholarly journals and beyond
We are entering an era of choice in terms of diabetes and obesity therapies. Choice is good, but having a keen understanding of each medication is crucial to avoid being…